Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| PI24/01913 | Registry Identifier | Instituto de Salud Carlos III |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Testing a clinical decision tool (BL-Predictor)
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| BL Predictor | Experimental | Parallel,non-inferiority, randomised control trial will be conducted in patients with a low-risk score stratified by BL-Predictor |
|
| control | Active Comparator | St followed, if negative,by a fractioned dose DTP wirth 30 min interval between doses: 25%-25%-50% of the maximun dose |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| BL-Predicter | Diagnostic Test | To Clinically validate the BL-Predictor toll by a randomised conytrolled ttrial |
|
| Measure | Description | Time Frame |
|---|---|---|
| The main goal of this project is to test a cliniacl decision toll to stratify BL allergic pataients in low and mediaum- anf high-risk | And to carry out a deep dissection of the cellular mechanisms of B cells sensitization and basophil and neutrophil activation in BL-IRs to develop accurate in vitro diagnostic test | April 2029- june 2027 |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Marina Labella Alvarez MLB Bonilla Toyos | Contact | +34951032058 | elvira.bonilla@ibima.eu |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
If there are other parties who are masked in the clinical trial besides those listed above, use this space to describe those parties.
Not provided
Not provided
If there are other parties who are masked in the clinical trial besides those listed above, use this space to describe those parties.
| ID | Term |
|---|---|
| D004342 | Drug Hypersensitivity |
| ID | Term |
|---|---|
| D064420 | Drug-Related Side Effects and Adverse Reactions |
| D064419 | Chemically-Induced Disorders |
Not provided
Not provided